105 related articles for article (PubMed ID: 32006876)
1. Serum levels of selected cytokines and soluble adhesion molecules in acute myeloid leukemia: Soluble receptor for interleukin-2 predicts overall survival.
Kupsa T; Vanek J; Zak P; Jebavy L; Horacek JM
Cytokine; 2020 Apr; 128():155005. PubMed ID: 32006876
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cytokines and soluble adhesion molecules in patients with newly diagnosed acute myeloid leukemia: the role of TNF-alpha and FLT3-ITD.
Kupsa T; Vanek J; Vasatova M; Karesova I; Zak P; Jebavy L; Horacek JM
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):94-9. PubMed ID: 26365931
[TBL] [Abstract][Full Text] [Related]
3. Biochip array technology and evaluation of serum levels of multiple cytokines and adhesion molecules in patients with newly diagnosed acute myeloid leukemia.
Horacek JM; Kupsa T; Vasatova M; Jebavy L; Zak P
Exp Oncol; 2014 Mar; 36(1):50-1. PubMed ID: 24691286
[TBL] [Abstract][Full Text] [Related]
4. Baseline serum levels of multiple cytokines and adhesion molecules in patients with acute myeloid leukemia: results of a pivotal trial.
Kupsa T; Vasatova M; Karesova I; Zak P; Horacek JM
Exp Oncol; 2014 Dec; 36(4):252-7. PubMed ID: 25537219
[TBL] [Abstract][Full Text] [Related]
5. Multi-analytical evaluation of serum levels of cytokines and adhesion molecules in patients treated for acute myeloid leukemia using biochip array technology.
Horacek JM; Vasatova M; Kupsa T; Jebavy L; Zak P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):277-9. PubMed ID: 24089084
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble adhesion molecules in newly diagnosed acute myeloid leukemia and in complete remission suggest endothelial cell activation by myeloblasts.
Kupsa T; Vanek J; Pavel Z; Jebavy L; Horacek JM
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):92-99. PubMed ID: 27833171
[TBL] [Abstract][Full Text] [Related]
7. Serum cytokine and adhesion molecule profile differs in newly diagnosed acute myeloid and lymphoblastic leukemia.
Horacek JM; Kupsa T; Vasatova M; Jebavy L; Zak P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):299-301. PubMed ID: 25363727
[TBL] [Abstract][Full Text] [Related]
8. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor α-Chain (CD25) Expression Predicts a Poor Prognosis.
Nakase K; Kita K; Kyo T; Ueda T; Tanaka I; Katayama N
PLoS One; 2015; 10(9):e0128998. PubMed ID: 26375984
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes.
Tsimberidou AM; Estey E; Wen S; Pierce S; Kantarjian H; Albitar M; Kurzrock R
Cancer; 2008 Oct; 113(7):1605-13. PubMed ID: 18683214
[TBL] [Abstract][Full Text] [Related]
11. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation.
Wang H; Li XQ; Chu TT; Han SY; Qi JQ; Tang YQ; Qiu HY; Fu CC; Tang XW; Ruan CG; Wu DP; Han Y
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2659-2670. PubMed ID: 33550446
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
Lange BJ; Yang RK; Gan J; Hank JA; Sievers EL; Alonzo TA; Gerbing RB; Sondel PM
Pediatr Blood Cancer; 2011 Sep; 57(3):398-405. PubMed ID: 21681921
[TBL] [Abstract][Full Text] [Related]
15. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
Dang H; Jiang A; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Jan; 44(1):55-61. PubMed ID: 22939316
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
18. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
19. FLT3-ITD and CD135 Over-Expression are Frequent Findings of Poor Survival in Adult Patients with Acute Leukemias.
Vela-Ojeda J; Cardenas PV; Garcia-Ruiz Esparza MA; Montiel Cervantes LA; Chavez JG; Caballero AH; Majluf-Cruz A; Vega-López A; Reyes-Maldonado E
Arch Med Res; 2021 Feb; 52(2):217-223. PubMed ID: 33109387
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia in an unselected patient population.
Suzuki R; Onizuka M; Kojima M; Shimada M; Okamura K; Fukagawa S; Tsuboi K; Kikuchi A; Kobayashi H; Shintani A; Ogawa Y; Kawada H; Hotta T; Ando K
Int J Hematol; 2007 Dec; 86(5):422-8. PubMed ID: 18192111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
